Position in ALXO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,536,625
+$1,258,747 QoQ
Shares Held
742,331
+435.6% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 94 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ALXO ranks #239 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ALXO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,536,625 | 742,331 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $277,878 | 138,593 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,506 | 17,262 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $34,027 | 18,594 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $120,222 | 289,693 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $232,511 | 373,214 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $950,244 | 569,009 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $467,519 | 256,879 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,297,968 | 215,252 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,750,572 | 157,002 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,351,162 | 90,743 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $629,409 | 131,127 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,350,049 | 179,767 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $816,523 | 180,647 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,977,445 | 175,461 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $1,538,338 | 160,746 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,004,240 | 247,743 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $3,624,813 | 214,486 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,990,074 | 139,138 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $12,038,883 | 162,996 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $7,454,687 | 136,333 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $18,684,609 | 253,385 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,346,333 | 131,628 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $278,558 | 7,381 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||